JP Patent

JP2024531670A — 塩素化テトラリン化合物及び医薬組成物

Assigned to SpringWorks Therapeutics Inc · Expires 2024-08-29 · 2y expired

What this patent protects

本開示は、塩素化テトラリン化合物及び医薬組成物に関する。

USPTO Abstract

本開示は、塩素化テトラリン化合物及び医薬組成物に関する。

Drugs covered by this patent

nirogacestat-hydrobromide (NIROGACESTAT HYDROBROMIDE)

Patent Metadata

Patent number: JP2024531670A
Jurisdiction: JP
Classification: —
Expires: 2024-08-29
Drug substance claim: No
Drug product claim: No
Assignee: SpringWorks Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.